Padagis US LLC recalls Trospium Chloride Extended-Release Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
- Products
-
- Trospium Chloride Extended-Release Capsules
- Company
- Padagis US LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 7,032 bottles
- About this recall
- Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30